AMN Healthcare to Present at the Oppenheimer 27th Annual Healthcare Conference

Thursday, March 2, 2017 General News J E 4

SAN DIEGO, March 2, 2017 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN), healthcare's leader and innovator in workforce solutions and staffing services, is scheduled to present at the Oppenheimer 27th Annual Healthcare Conference on Wednesday, March 22, 2017 at 1:35 p.m. Eastern Time at the Westin New York Grand Central Hotel in New York, New York. Susan Salka, Chief Executive Officer of AMN Healthcare, will be presenting at the conference. An audio webcast, as well as a copy of the investor presentation, will be available on the Company's investor relations website at on the day of the event. Participants will need to allow adequate time to download any software necessary for the webcast.

About AMN Healthcare

AMN Healthcare is the leader and innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. The Company provides unparalleled access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN delivers managed services programs, healthcare executive search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, medical coding and consulting, and other services. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities and many other healthcare settings.  For more information about AMN Healthcare, visit   

Contact:Neil ThomasSenior Director, Investor Relations866-861-3229Web site:


To view the original version on PR Newswire, visit:

SOURCE AMN Healthcare Services, Inc.



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
GenomeDx Biosciences Announces Initiation by Michi...
How These Generic Drugs Stocks are Faring? -- Dipl...